MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

18.70
-0.17
-0.88%
Opening 11:27 04/02 EDT
OPEN
18.70
PREV CLOSE
18.87
HIGH
18.70
LOW
18.70
VOLUME
262
TURNOVER
--
52 WEEK HIGH
24.57
52 WEEK LOW
12.00
TOTAL ASSET
32.10M
YTD YIELD
-19.52%
1D
5D
1M
3M
1Y
5Y

CNCR News

More
  • Will These Tech Stock Valuations Last?
  • Seeking Alpha - Article · 02/13 13:06
  • Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
  • Seeking Alpha - Article · 02/10 14:35
  • Investing In The Holy Grail Of Cancer Treatment: Immunotherapy
  • Seeking Alpha - Article · 11/22/2019 18:34
  • VXX, UNG, UGAZ and TVIX among weekly ETF movers
  • Seeking Alpha - Article · 11/01/2019 20:54

Profile

Fund Name
Loncar Cancer Immunotherapy ETF
Risk
High Risk
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD*100.0%
Advisor Company
Loncar Investments
Custodian
U.S. Bank N.A
Manager
Denise Krisko, Austin Wen

Asset Allocation

30.88M
  • 100.00%
  • 0.00%
  • 0.00%
  • 0.00%

2020 Q1

30.88M

2019 Q4

39.92M

2019 Q2

38.09M

2019 Q1

38.87M

2018 Q4

38.54M

Dividend History

Ex-Div Date
Dividend Per Share
12/28/2017
0.3502
12/29/2015
0.1055